Datametrex - CEO, Marshall Gunter.
CEO, Marshall Gunter.
Source: LinkedIn
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Datametrex AI (DM) subsidiary, Nexalogy Environics is partnering with Medi-Call in the fight against suicide
  • Medi-Call will utilize Nexalogy’s AI Social Media Automated Reporting Technologies (SMART) to filter through and identify patterns from online social media postings
  • Suicide is the second leading cause of death among youth and young adults
  • There is increasing evidence that social media can influence suicide-related behaviour with cyberbullying and cyber harassment online
  • SMART allows an analyst to deal with hundreds of thousands of social media documents in minutes
  • Datametrex AI Ltd is a Canada-based information technology company
  • Datametrex AI Limited (DM) opened trading at C$0.11

Datametrex AI (DM) subsidiary, Nexalogy Environics is partnering with Medi-Call in the fight against suicide.

Medi-Call will utilize Nexalogy’s AI Social Media Automated Reporting Technologies (SMART) to filter through and identify patterns from online social media postings to detect those who may be suffering from mental illness and who may need support.

Nexalogy’s SMART AI tool can gather sets of information within minutes and can filter through hundreds of thousands of social media documents to detect social postings surrounding mental health and suicide.

The government of Canada reports that an average of 10 Canadians die each day by suicide. That’s approximately 4,000 deaths by suicide per year and is the second leading cause of death among youth and young adults. 

There is increasing evidence that social media can influence suicide-related behaviour with cyberbullying and cyber harassment online. Over 40 percent of cyberbullying happens through online social media platforms.

Nexalogy’s Smart AI tool can detect those who are posting and prevent mental harm, suicide and other mental health issues that could lead to suicide by offering Medi-Call’s Mental Health services and support.

Marshall Gunter, CEO of Datametrex, commented on the news.

“The latest data shows that people are dealing with mental health now more than ever. Data from the CMHA suggests 37 per cent of British Columbians’ mental health has declined during the pandemic. Together with Medi-Call, our AI solutions, can assist in detecting those who are suffering and help provide a solution.”

 Dr. Omar Sharif, Chief Medical Officer of Datametrex added,

“There is an urgent need for mental health support and healthcare within Canada. The Canadian Institute for Health Information reported that half of Canadians waited up to 1 month for mental health services, while 1 in 10 waited more than 4 months before receiving care. Medi-Call’s mission is to fill in that gap so patients can receive the treatment and support they need.”

SMART reduces the time needed to interpret and integrate large sets of data by offering powerful automated analyses. SMART allows an analyst to deal with hundreds of thousands of social media documents in minutes rather than hours or days.

Analysts can specify filters on the data to get automatic reports on subsets of the data focusing on specific times, entities, social media users, or topics.

Datametrex AI Limited is a technology-focused company with exposure to artificial intelligence, machine learning, telehealth and has recently entered the electric vehicle (EV) market.

Datametrex AI Limited (DM) opened trading at C$0.11.


More From The Market Herald
Emerald Health Therapeutics Inc. - Director & Chairman, Jim Heppell.

" Emerald Health (CSE:EMH) shareholders approve merger

Emerald Health Therapeutics (EMH), has received shareholders’ approval for the proposed plan of arrangement with Skye Bioscience Inc.
Mydecine Innovations Group - CEO, Josh Bartch.

" Mydecine (NEO:MYCO) raises $244K and shifts management team

Mydecine Innovations Group (MYCO) has signed a common share subscription agreement with a third-party investor for proceeds up to $244,99.50.
PharmaDrug - CEO, Daniel Cohen

" PharmaDrug (CSE:PHRX) completes milestone to support cGMP production of PD-001

PharmaDrug (PHRX) has laid the groundwork to support cGMP production of cepharanthine-2HCL for use in the drug product production of PD-001.

" EQ (TSXV:EQ) reports strongest quarter in over a decade

EQ (EQ) reported its financial results for the second quarter ended June 30, 2022, announcing the highest second-quarter revenue in over a decade.